| Logo | Name | Σ | ||
|---|---|---|---|---|
 | Institut Analgesia [Automatic translation follows] 1st foundation for research against pain in France A major public health problem, chronic pain now affects 1 in 5 adults, or more than 12 million French people. And since the therapeutic arsenal is both aging and insufficient, nearly two thirds of patients believe that their pain is insufficiently controlled. Pain also has a very significant impact on health at work. Back pain is the leading cause of disability in the world and musculoskeletal disorders are the leading cause of occupational illness in France. Pain alone impacts 88 million working days per year in France. Fighting pain … Sectors: | 176 | 42 | 133 |
 | Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: | 3471 | 2589 | 832 |
 | Orange Orange is here. Orange is one of the world’s leading telecommunications operators with revenues of 39.7 billion euros in 2023 and 128,000 employees worldwide at 30 June 2024, including 72,000 employees in France. The Group has a total customer base of 285 million customers worldwide at 30 June 2024, including 246 million mobile customers and 21 million fixed broadband customers. The Group is present in 26 countries. Orange is also a leading provider of global IT and telecommunication services to multinational companies under the brand Orange Business. In February 2023, the Group presented its strategic plan "Lead the Future", built … Tags: CAC40 Sectors: | 5746 | 4605 | 761 |
 | Leem [Automatic translation follows] The professional organization of pharmaceutical companies operating in France. Leem, Les Entreprises du médicament, brings together companies in the pharmaceutical industry sector in France. Created over 130 years ago, Leem now has nearly 270 member companies, which generate nearly 98% of the total pharmaceutical turnover in France. The pharmaceutical industry employs 100,000 people in over 150 professions, and has recruited 10,000 employees per year for the past 10 years. Each year, the pharmaceutical industry invests 12% of its turnover in research, in order to develop new innovative treatments. It brings together more than 20,000 people in its … Sectors: | 717 | 383 | 261 |
 | Clubster NSL [Automatic translation follows] 360 members | #innovation #health #nutrition #longevity | contact@clubster-nsl.com Clubster Santé, a network of health companies in the Nord-Pas de Calais region, aims to develop, promote, represent and lead the regional health sector. Our network has major unifying missions: to be the spokesperson for the regional health sector, to facilitate exchanges and partnerships between companies and to support a dynamic and wealth-creating sector via a specialized investment platform. Personalized medicine, Inter-company training, HIPÂ, Concept Room, Invest'Innove, Investment platform, Information, Mutualization, Innovation, Networking, Business Angels Academy, nutrition, longevity, and eurasanté Sectors: | 287 | 97 | 213 |
 | Atlanpole Biotherapies Thinking up tomorrow's medicine Atlanpole Biotherapies is a French biocluster that gives you access to extended skills, from biodiagnostic to biomedicine. For pharmaceutical and biotech companies or research laboratories looking for high level partners committed to healthcare and biotechnologies, Atlanpole Biotherapies is a biocluster that draws together a network of industrial and academic competences which offers comprehensive and competitive solutions along the entire biotherapeutic value chain, from discovery to patient,within 4 areas of excellence: • immunobiotherapies • radiopharmaceuticals • biomaterials • cell & gene therapies More information : http://www.atlanpolebiotherapies.com Biotechnologies, Bioproduction, Pharma, Technologies médicales innovantes, MedTech, Numérique pour la santé, … Sectors: | 312 | 121 | 204 |
 | Greater Paris University Hospitals - AP-HP Nous soignons et innovons 365 jours par an. AP-HP (Greater Paris University Hospitals) is a European world-renowned university hospital. Its 39 hospitals treat 8 million people every year: in consultation, emergency, during scheduled or home hospitalizations. The AP-HP provides a public health service for everyone, 24 hours a day. This mission is a duty as well as a great source of pride. AP-HP is the leading employer in the Greater Paris area: 100.000 staff members – doctors, researchers, paramedical staff, administrative personnel and workers – work there. Toutes les spécialités médicales de la néonatologie à la gériatrie en passant par … Sectors: | 2144 | 1470 | 149 |
 | France Biotech Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: … Sectors: | 829 | 483 | 507 |
 | Roche Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, … Sectors: | 1562 | 1422 | 60 |
 | DOCAPOSTE Digital trust leader in France 🔵 Digital trust leader in France and subsidiary of La Poste Group, Docaposte supports all companies and public institutions in their transformation and allows them to accelerate it, with confidence. The digital trust reference in France Docaposte provides a simple, fast and secure digital experience for everyone, supporting businesses and public institutions in their digital journey. Experts in processing sensitive data, Docaposte's unique positioning allows us to meet client needs from end-to-end, working on the whole data value chain to create an unrivalled trust chain. Docaposte's mission is to guarantee your digital independence whilst respecting … Sectors: | 878 | 539 | 314 |
 | Assurance Maladie [Automatic translation follows] Working at Health Insurance means giving a new dimension to your job and acting every day to protect our health system. Participate in a wide variety of projects in a caring environment and be proud to contribute to an essential mission: acting together, protecting everyone. For nearly 80 years, Health Insurance has played a major role in serving national solidarity. We are convinced that the key to the sustainability of the health system is a collective responsibility and lies in the strong involvement of each of its stakeholders. Within this system, Health Insurance has a triple mission: … Sectors: | 1504 | 965 | 359 |
 | Syneos Health Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment. Clinical Trials and Biopharmaceutical Product Lifecycle Management Sectors: | 138 | 122 | 20 |
 | Pfizer We’re celebrating 175 years of daring scientific innovation—and we’re not done yet. Every day, we’re channeling our passion and resources into delivering innovative therapies that change the face of healthcare. Let’s outdo yesterday. Follow our progress as we accelerate the next generation of cancer treatments at LetsOutdoCancer.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines To apply science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe and effective and affordable medicines and health care services to the people who need them. Sectors: | 1358 | 1054 | 137 |
 | Haute Autorité de Santé [Automatic translation follows] Official page of the High Authority for Health (HAS), an independent public authority of a scientific nature The HAS is an independent public authority whose aim is to contribute to the regulation of the health system through quality. Its missions in the fields of the evaluation of health products, professional practices, the organization of care and public health, aim to ensure that all patients and users have sustainable and equitable access to care that is as effective, safe and efficient as possible. | 441 | 322 | 109 |
 | Alexion Pharmaceuticals, Inc. Transforming Lives, Every Day. Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies, and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex … Sectors: | 263 | 187 | 35 |
 | Ipsen We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries. For more information, visit ipsen.com. Pauta exclusiva para México: Clave de Autorización COFEPRIS: 243300201B1962 CONSULTE A SU MÉDICO. Pharmaceuticals, Specialty care: oncology, neuroscience, endocrinology, Research: peptides, toxins, … Sectors: | 385 | 332 | 55 |
 | Cryoport Systems (formerly Cell&Co) A Cryoport Company - ATMP & Clinical sample management - www.cell-and-co.com Expert in GMP products management & Clinical sample management activities, Cell&Co BioServices, subsidiary of Cryoport Systems, offers a complete one-stop-shop solution for managing GMP-products and biological-samples. Our mission is to give you a reliable solution of storage, packaging, traceability, and trustfull logistic services. Cell&Co is the first and most important french private biorepository ; recognized, certified and having regulatory authorizations, with the highest and non challenged capacity. With two GMP plants, Cell&Co is offering mirroring storage capacities from -196°C to +20°C. We mainly support our clients by providing the … Sectors: | 18 | 9 | 9 |
Research